Neurostimulation Market Forecast and Segments, 2014-2020
- Submitted by: Monica2016
- Views: 50
- Category: Other
- Date Submitted: 09/12/2016 12:06 AM
- Pages: 3
- Report this Essay
Neurostimulation is used for the treatment of various debilitating conditions such as gastroparesis, incontinence, Parkinson’s disease, epilepsy, depression and essential tremors. Neurostimulation is a highly potential treatment option for patients who do not obtain relief from medications and surgical therapies. It improves the quality of life of patients who are severely paralyzed or suffering from intense loss of various sense organs. Therefore, neurostimulation is highly instrumental in artificial vision, hearing aids, artificial limbs and other prosthetics.
The global neurostimulation market is analyzed based on the therapies in which neurostimulation systems are utilized. This includes the following segments:
• Deep brain stimulation (DBS)
• Spinal cord stimulation (SCS)
• Vagus nerve stimulation (VNS)
• Sacral nerve stimulation (SNS)
Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-400
Spinal cord stimulation therapy accounts for the largest share in the global neurostimulation market owing to the presence of a large number of SNS neurostimulators in treating diabetic neuropathy, pain, postherpetic neuralgia, ischemic limb pain and acute herpes zoster pain. Deep brain stimulators are currently approved for the treatment of neurological disorders such as Parkinson’s disease, epilepsy, dystonia, obsessive-compulsive disorder (OCD), essential tremors and depression. However, extensive research and advancement in technology leading to new, exciting applications such as stroke, obesity, autism, sleep disorders and many others will expand the deep brain stimulator market at a faster pace.
There is a rising need for devices with improved outcome, ability to pre-sense a neurological episode on-set, optimize the inter-device communication and better user interface. Developing technologies sufficing the treatment objective and market demand will lead to an increase in the demand for neurostimulation therapy and...
The global neurostimulation market is analyzed based on the therapies in which neurostimulation systems are utilized. This includes the following segments:
• Deep brain stimulation (DBS)
• Spinal cord stimulation (SCS)
• Vagus nerve stimulation (VNS)
• Sacral nerve stimulation (SNS)
Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-400
Spinal cord stimulation therapy accounts for the largest share in the global neurostimulation market owing to the presence of a large number of SNS neurostimulators in treating diabetic neuropathy, pain, postherpetic neuralgia, ischemic limb pain and acute herpes zoster pain. Deep brain stimulators are currently approved for the treatment of neurological disorders such as Parkinson’s disease, epilepsy, dystonia, obsessive-compulsive disorder (OCD), essential tremors and depression. However, extensive research and advancement in technology leading to new, exciting applications such as stroke, obesity, autism, sleep disorders and many others will expand the deep brain stimulator market at a faster pace.
There is a rising need for devices with improved outcome, ability to pre-sense a neurological episode on-set, optimize the inter-device communication and better user interface. Developing technologies sufficing the treatment objective and market demand will lead to an increase in the demand for neurostimulation therapy and...